University of New Mexico
Albuquerque, New Mexico, 87131, United States
NCT Number: NCT03808909
This study will determine the feasibility of offering expanded continuous labor support by trauma- and addiction-trained medical paraprofessionals (i.e. doulas) at no cost to pregnant women receiving care for substance use disorders (SUD). The long-term goal of this transdisciplinary multilevel intervention is ultimately to reduce a major existing behavioral health disparity in the state. This cross-campus multi-disciplinary collaboration, is in partnership with Young Women United (a research and policy organization in NM) and doulas of the UNM Birth Companion Program. Through this partnership, women receiving combined OB/SUD treatment at the Milagro Program at UNMHSC will be offered expanded doula services.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Albuquerque, New Mexico, 87131, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants in the intervention condition will be assigned a doula who is a lay person trained to provide emotional and practical support to individuals throughout labor and delivery.
Time frame: 2 week postpartum follow-up assessment
Number of participants who complete the 2 week follow-up
Time frame: birth
Number of participants with preterm, c-section, fetal demise, still birth, or other potential birth outcomes
Time frame: 2 week postpartum follow-up assessment
PTSD Checklist - 5 (PCL-5) Higher scores indicate a worse outcome Range of scale = 0 - 80
Time frame: 2 week postpartum follow-up assessment
Study specific participant satisfaction - debriefing form - qualitative data. No qualitative analyses have been conducted with this data.
Time frame: 2 week postpartum follow-up assessment
Using the timeline followback we will calculate average percentage of days of alcohol or other substance use for each group from pregnancy recognition to the 2 week follow-up.
Time frame: queries feelings during labor and birth but is administered at 2 week follow-up
Mother's Autonomy in Decision Making Questionnaire Higher scores indicate more autonomy (better outcome) Scale range = 7 - 42
Time frame: 2 week postpartum follow-up assessment
Edinburgh Postpartum Depression Scale Higher scores are a worse outcome Scale range = 0-30
Time frame: 2 week postpartum follow-up assessment
Using a study specific form we will calculate the number of participants who attempted breastfeeding after the birth of the baby
Time frame: neonatal
NAS diagnosis
Time frame: from birth through study completion, an average of 3 months
Average length of time that the infant remains hospitalized in the NICU after the birth
Time frame: 2 week postpartum follow-up assessment
Average score for social support on NIH toolbox Total of Emotional, Friend, and Instrumental Social support scales Higher scores indicated a better outcome Scale range = 24 - 120
University of New Mexico
Other
Acronym: Project_SuM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07707115
Behavior, Bias, Implicit
Salt Lake City, Utah, United States
View Trial DetailsNCT04939012
Chemically-Induced Disorders, Contraception
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT04459000
Chemically-Induced Disorders, Child Neglect
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT05534568
Alcohol Use Complicating Pregnancy, Childbirth, and the Puerperium, Alcohol Use Complicating Pregnancy, First Trimester
Oklahoma City, Oklahoma, United States
View Trial Details